<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9">
 <label>9.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hansen</surname>
    <given-names>MB</given-names>
   </name>
   <name>
    <surname>Norgaard</surname>
    <given-names>LS</given-names>
   </name>
   <name>
    <surname>Hallgreen</surname>
    <given-names>CE</given-names>
   </name>
  </person-group>
  <article-title>How and why to involve patients in drug development: perspectives from the pharmaceutical industry, regulatory authorities, patient organizations</article-title>. 
  <source>Therap Innov Regul Sci.</source> (
  <year>2020</year>) 
  <volume>25</volume>:
  <fpage>577</fpage>â€“
  <lpage>85</lpage>. 
  <pub-id pub-id-type="doi">10.1177/2168479019864294</pub-id>
 </mixed-citation>
</ref>
